NORTH AMERICAN PATENT HOLDINGS, INC. – Trademark Portfolio
Entity Type: 03
NORTH AMERICAN PATENT HOLDINGS, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ICE BAN. The owner is based in VIRGINIA BEACH, VA.
977 CENTERVILLE TURNPIKE
VIRGINIA BEACH, VA 23463
Showing of trademarks Trademarks
Trademark Classifications
NORTH AMERICAN PATENT HOLDINGS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NORTH AMERICAN PATENT HOLDINGS, INC. have?
NORTH AMERICAN PATENT HOLDINGS, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 4 cancelled.
What trademark classes does NORTH AMERICAN PATENT HOLDINGS, INC. file in?
NORTH AMERICAN PATENT HOLDINGS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are NORTH AMERICAN PATENT HOLDINGS, INC.'s most well-known trademarks?
NORTH AMERICAN PATENT HOLDINGS, INC.'s registered trademark portfolio includes well-known marks such as ICE BAN. These are among 1 currently registered trademark in the portfolio.
What is NORTH AMERICAN PATENT HOLDINGS, INC.'s trademark registration success rate?
NORTH AMERICAN PATENT HOLDINGS, INC. has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.